We report a new and efficient ruthenium-catalyzed reaction that transforms ethynyl alcohol into alkene and carbon monoxide. The most efficient catalysts are TpRu(PPh3)(CH3CN)2PF6 (10 mol %) and lithium triflate (20 mol %). The mechanism of this reaction was elucidated using an isotope-labeling experiment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/ja036246w | DOI Listing |
Pharmacol Biochem Behav
January 2025
Department of Psychology, Arizona State University, Tempe, AZ 85257, United States of America. Electronic address:
Glutamatergic signaling is one of the primary targets of actions of alcohol in the brain, and dysregulated excitatory transmission in the prefrontal cortex (PFC) may contribute problematic drinking and relapse. A prominent component of glutamate signaling is the type 5 metabotropic glutamate (mGlu5) receptor. However, little is known about the role of this receptor type in subregions of the PFC that regulate either alcohol intake or alcohol-seeking behavior.
View Article and Find Full Text PDFJ Anim Sci Technol
July 2024
Division of Animal & Dairy Science, Chungnam National University, Daejeon 34134, Korea.
This study was conducted to investigate whether lysophosphatidic acid (LPA) could improve the development of porcine somatic cell nuclear transfer (SCNT) embryos. Porcine SCNT-derived embryos were cultured in chemically defined polyvinyl alcohol (PVA)-based porcine zygote medium (PZM)-4 without or with LPA, and the development, cell proliferation potential, apoptosis, and expression levels of pluripotent markers were evaluated. LPA significantly increased the rates of cleavage and blastocyst formation compared to those seen in the LPA un-treatment (control) group.
View Article and Find Full Text PDFACS Appl Mater Interfaces
February 2024
Department of Chemistry, Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Fudan University, 2005 Songhu Road, Shanghai 200438, P. R. China.
Tohoku J Exp Med
March 2024
Department of Basic Medical, Xingtai Medical College.
SKI-349 is a novel sphingosine kinases (SPHK) inhibitor with anti-tumor effects. This study aimed to assess the effect of SKI-349 on cell biological behaviors, downstream pathways, and its synergistic effect with sorafenib in hepatocellular carcinoma (HCC). HCC cell lines (Huh7 and Hep3B) were treated with SKI-349 at concentrations of 1, 2, 4, or 8 μM.
View Article and Find Full Text PDFPhys Chem Chem Phys
January 2024
Key Laboratory for Green Chemical Technology of Ministry of Education, R & D Center for Petrochemical Technology, Tianjin University, Tianjin, 300072, P. R. China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!